Monthly Communication Reports in:
April
2019
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Teva Canada Limited/Teva Canada Limitee
Christine
Poulin,
Senior Vice President and General Manager
(Corporation)
-
Teva Canada Limited
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Celia Lourenco,
Director General
| Biologics and Genetic Therapies Division (BGDT)
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2019-04-23
Posted date:
2019-05-15
Communication number:
235321-451085
View associated registration
